New Delhi, March 14 Zydus Lifesciences announced on Saturday that its innovative drug has received approval from China's National Medical Products Administration (NMPA) for its Desidustat tablets, used to treat renal anemia.The company has licensed its Desidustat tablets to a subsidiary of...
china
china medical system
chronic kidney disease
ckd
desidustat
drug approval
greater china
healthcare
kidney failure
licensing
medicalproducts
medicine
oxemia
patient outcomes
renal anemia
zydus lifesciences
Raipur, February 28. Chhattisgarh is set to join the nationwide 'Jan Aushadhi Week' celebrations from March 1 to 7, 2026, under the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP).Organized by the Pharmaceuticals and Medical Devices Bureau of India (PMBI), under the Department of...
India and Brazil have exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the regulation of pharmaceutical and medical products. In a statement, the Ministry of Health and Family Welfare informed that the MoU was exchanged between India's Central Drugs Standard...
anvisa
bilateral cooperation
brazil
cdsco
dinesh bhatia
health regulation
india
leandro safatle
luiz inácio lula da silva
medicalproducts
memorandum of understanding
narendra modi
new delhi
pharmaceutical regulation
regulatory affairs